Anchor Investment Management, LLC Amgen Inc Transaction History

Anchor Investment Management, LLC

$954 Billion
Q1 2024

A detailed history of Anchor Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Anchor Investment Management, LLC holds 6,024 shares of AMGN stock, worth $1.95 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

6,024

Previous 5,106 17.98%

Holding current value

$1.95 Million

Previous $1.47 Billion 16.48%

% of portfolio

0.18%

Previous 0.17%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $246,822 - $297,946	918 Added 17.98%	6,024 $1.71 Billion
Q4 2023 Jan 02, 2024	BUY	$255.7 - $288.46 $1.31 Million - $1.47 Million	5,106 New	5,106 $1.47 Billion
Q3 2023 Jan 02, 2024	SELL	$218.65 - $271.46 $35,639 - $44,247	-163 Reduced 2.99%	5,294 $1.42 Billion
Q2 2023 Jan 02, 2024	SELL	$214.27 - $253.37 $61,924 - $73,223	-289 Reduced 5.03%	5,457 $1.21 Billion
Q1 2023 Jan 02, 2024	SELL	$225.79 - $275.2 $205,694 - $250,707	-911 Reduced 13.68%	5,746 $1.39 Billion
Q4 2022 Jan 02, 2024	BUY	$229.03 - $291.01 $355,225 - $451,356	1,551 Added 30.38%	6,657 $1.75 Billion
Q3 2022 Jan 02, 2024	BUY	$224.46 - $253.15 $200,442 - $226,062	893 Added 17.49%	5,999 $1.35 Billion
Q2 2022 Jan 02, 2024	SELL	$230.71 - $256.74 $62,060 - $69,063	-269 Reduced 4.27%	6,026 $1.47 Billion
Q1 2022 Jan 02, 2024	BUY	$219.27 - $242.57 $1,973 - $2,183	9 Added 0.14%	6,295 $1.52 Billion
Q4 2021 Jan 02, 2024	SELL	$198.88 - $227.6 $161,689 - $185,038	-813 Reduced 11.45%	6,286 $1.41 Billion
Q3 2021 Jan 02, 2024	BUY	$212.27 - $248.7 $423,054 - $495,659	1,993 Added 39.03%	7,099 $1.51 Billion
Q2 2021 Jan 02, 2024	SELL	$233.58 - $259.14 $52,555 - $58,306	-225 Reduced 2.65%	8,266 $2.01 Billion
Q1 2021 Jan 02, 2024	BUY	$221.91 - $258.6 $333,974 - $389,193	1,505 Added 21.54%	8,491 $2.11 Billion
Q4 2020 Jan 02, 2024	SELL	$216.38 - $257.67 $5,625 - $6,699	-26 Reduced 0.37%	6,986 $1.61 Billion
Q3 2020 Jan 02, 2024	BUY	$234.65 - $260.95 $447,242 - $497,370	1,906 Added 37.33%	7,012 $1.78 Billion
Q2 2020 Jan 02, 2024	BUY	$197.81 - $242.74 $24,726 - $30,342	125 Added 1.83%	6,968 $1.64 Billion
Q1 2020 Jan 02, 2024	BUY	$182.24 - $241.7 $34,625 - $45,923	190 Added 2.86%	6,843 $1.39 Billion
Q4 2019 Jan 02, 2024	SELL	$189.21 - $243.2 $10,406 - $13,376	-55 Reduced 0.82%	6,653 $1.6 Billion
Q3 2019 Jan 02, 2024	BUY	$174.11 - $208.62 $278,924 - $334,209	1,602 Added 31.37%	6,708 $1.3 Billion
Q2 2019 Jan 02, 2024	SELL	$166.7 - $195.41 $41,675 - $48,852	-250 Reduced 3.59%	6,708 $1.24 Billion
Q1 2019 Jan 02, 2024	SELL	$180.87 - $203.88 $83,381 - $93,988	-461 Reduced 6.21%	6,958 $1.32 Billion
Q4 2018 Jan 02, 2024	BUY	$178.4 - $208.25 $24,084 - $28,113	135 Added 1.85%	7,419 $1.44 Billion
Q3 2018 Jan 02, 2024	BUY	$185.29 - $208.89 $403,561 - $454,962	2,178 Added 42.66%	7,284 $1.51 Billion
Q2 2018 Jan 03, 2024	BUY	$166.05 - $186.51 $327,284 - $367,611	1,971 Added 38.6%	7,077 $1.31 Billion
Q1 2018 Jan 03, 2024	BUY	$169.43 - $198.0 $11,012 - $12,870	65 Added 0.94%	6,958 $1.19 Billion
Q4 2017 Jan 03, 2024	SELL	$168.79 - $188.59 $86,926 - $97,123	-515 Reduced 6.95%	6,893 $1.2 Billion
Q3 2017 Jan 03, 2024	BUY	$167.29 - $191.0 $4,182 - $4,775	25 Added 0.34%	7,408 $1.38 Billion
Q2 2017 Jan 03, 2024	BUY	N/A	2,277 Added 44.59%	7,383 $1.27 Billion
Q1 2017 Jan 03, 2024	BUY	N/A	1,933 Added 35.27%	7,413 $1.22 Billion
Q4 2016 Jan 03, 2024	BUY	N/A	647 Added 13.39%	5,480 $801 Million
Q3 2016 Jan 03, 2024	BUY	N/A	160 Added 3.42%	4,833 $806 Million
Q2 2016 Jan 03, 2024	SELL	N/A	-433 Reduced 8.48%	4,673 $711 Million
Q1 2016 Jan 03, 2024	SELL	N/A	-413	4,693 $704 Million

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $174B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.

Account

Anchor Investment Management, LLC Amgen Inc Transaction History